← back to search

Zitong Wang

Harbin Medical University · CN
🔎 Find collaborators in Physiology · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Physiology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Adenocarcinoma and NFAT, with related work in Lytic cycle, Gene expression, Muscle hypertrophy. Notable publications include 'Targeting miR-30d reverses pathological cardiac hypertrophy', 'Advancing single-cell RNA-seq data analysis through the fusion of multi-layer perceptron and graph neural network', and 'Characterization and genome analysis of Klebsiella phage P509, with lytic activity against clinical carbapenem-resistant Klebsiella pneumoniae of the KL64 capsular type'.
h-index
citations
132
works
7
NIH funding
primary concept
email

Recent publications

Discovering biomarkers associated with infiltration of CD8+ T cells and tumor-associated fibrosis in colon adenocarcinoma using single-cell RNA sequencing and gene co-expression network
Frontiers in Immunology 2025cited by 2position: middledoi
Advancing single-cell RNA-seq data analysis through the fusion of multi-layer perceptron and graph neural network
Briefings in Bioinformatics 2023cited by 29position: middledoi
Targeting miR-30d reverses pathological cardiac hypertrophy
EBioMedicine 2022cited by 60position: middledoi
Associations of intermuscular adipose tissue and total muscle wasting score in PG-SGA with low muscle radiodensity and mass in nonmetastatic colorectal cancer: A two-center cohort study
Frontiers in Nutrition 2022cited by 12position: middledoi
Icotinib, an EGFR tyrosine kinase inhibitor, as adjuvant therapy for patients with stage IIA-IIIA EGFR-mutant non-small-cell lung adenocarcinoma: a multicenter, open-label, single-arm, phase II study (ICAPE)
Investigational New Drugs 2022cited by 3position: middledoi
Abstract 5499: Efficacy of icotinib as adjuvant therapy for patients with stage IIA-IIIA EGFR-mutant non-small-cell lung adenocarcinoma: a multicenter, open-label, single-arm, phase II study (ICAPE)
Cancer Research 2022cited by 0position: middledoi
Characterization and genome analysis of Klebsiella phage P509, with lytic activity against clinical carbapenem-resistant Klebsiella pneumoniae of the KL64 capsular type
Archives of Virology 2020cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Huagang Liang · Hebei Medical University2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022)Lijun Liu · Ministry of Education of the People's Republic of China2 papers (2022–2022)Yu Liu · Hebei Medical University2 papers (2022–2022)Guodong Li · South China Agricultural University2 papers (2022–2025)Liming Yang · China Three Gorges Corporation (China)2 papers (2022–2023)Yi Zhang · Capital University1 papers (2022–2022)Jiahong Xu · Soochow University1 papers (2022–2022)Yunxiao Liu · Harbin Medical University1 papers (2022–2022)Jin Li · Nantong University1 papers (2022–2022)Tingting Yang · Ernst Ruska Centre1 papers (2022–2022)Zitai Qi · Nanjing Agricultural University1 papers (2020–2020)Ming He · Shanghai Jiao Tong University1 papers (2022–2022) · 1 papers (2023–2023)Junjie Xiao · Shanghai University1 papers (2022–2022)Yuwei Yan · Nantong University1 papers (2022–2022)Saumya Das · Harvard University1 papers (2022–2022)Xia Jiang · Xuzhou Medical College1 papers (2022–2022)Guiyu Wang · Harbin Medical University1 papers (2022–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Physiology · Pulmonary and Respiratory Medicine →